Brain Death: Inflammatory Response, Apoptosis, and Endotoxin Tolerance
Observational Study on the Systemic Inflammatory Response During Brain Death.
Sponsor: Delafontaine Hospital
This observational or N/A phase trial investigates Brain Death and is currently completed. Delafontaine Hospital leads this study, which shows 7 recorded versions since 2000 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
▶ Show 2 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Jan 2000
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Delafontaine Hospital
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Liège, Belgium
- • Paris, France
- • Saint-Denis, France